Abstract:Background: Halogenated corticosteroids are widely used in medicine, and the global need of these steroidal APIs is estimated to be 40 - 70 tons, annually. Vietnam currently imports the pharmaceutical compounds up to 90%, in particular 100% of steroidal drugs. Currently, industrial production is based on the chemical syntheses of corticosteroids from either 16- dehydropregnenolone acetate (obtained from diosgenin) or androstenedione (obtained from phytosterol). The development of shorter synthetic schemes and more economically feasible technologies is of great significance. Introduction of 1(2)-double bond at the final stages of the corticosteroids synthesis results inpoor yield. 21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione (tetraene acetate) is a key intermediate in the synthesis of highly active halogenated corticosteroids such as dexamethasone and other halogenated corticosteroids. 21-acetoxypregna-1,4,9(11),16- tetraene-3,20-dione is a key intermediate in the synthesis of dexamethasone from the readily available and cheap 9α-hydroxyandrost-4-ene-3,17-dione. Objective: The purpose of this study was the development of an efficient and shorter procedure for the synthesis of 21-acetoxypregna-1,4,9(11),16-tetraene-3,20-dione from 9α-hydroxyandrostenedione, which is a product of a bio-oxidative degradation of the side chain of phytosterols. Methods: Pregnane side chain was constructed using cyanohydrin method. For 1(2)- dehydrogenation, selene dioxide was applied for the introduction of Δ1(2)-double bond. Other stages of the synthesis were epimerization, Stork's iodination procedure and dehydration. Result: 21-Acetoxypregna-1,4,9(11),16-tetraene-3,20-dione was prepared from 9α- hydroxyandrostenedione in yield more than 46%. Conclusion: An efficient and practically feasible procedure for the synthesis of 21-acetoxypregna- 1,4,9(11),16-tetraene-3,20-dione from 9α-hydroxyandrostenedione, a key intermediate for the synthesis of 9-haloidated corticoids, has been developed. The procedure can be applied for the production of value-added 9-haloidated corticoids.

Synthesis of 3Β-Hydroxyandrost-4-en-6,17-dione

Synthesis technology of 3-n-propyl-2, 4-dihydroxyacetophenone

New Synthesis Process of 2,7-Dimethyl-2,4,6-octatriene-1,8-dial

An Efficient Synthesis of 5Α-Androst-1-ene-3,17-dione

A Highly Stereoselective Synthesis of C-24 and C-25 Oxysterols from Desmosterol.

Practical synthesis of androgen: the efficient transformation of 17-oxo group to 17α-hydroxy group

A practical chemical synthesis of avicholic acid

A Designed Chemoenzymatic Route for Efficient Synthesis of 6-Dehydronandrolone Acetate: A Key Precursor in the Synthesis of C7-Functionalized Steroidal Drugs

An Efficient Procedure for the Synthesis of 21-Acetoxypregna-1,4,9(11),16- tetraene-3,20-dione

Synthesis of 16α,17α-epoxypregn-4-ene-3,20-dione and optimization of the technological conditions

Improved Synthesis of 17-(5′-isoxazolyl)androst-4,16-dien-3-one,a Potential Agent for the Treatment of Prostate Cancer

Studies on Synthesis of Finasteride

SYNTHESIS OF (17R) AND (17S)-17-HYDROXY-14,15-SECOANDROST-4-EN-16-YN-3-ONE AND THE X-RAY CRYSTAL-STRUCTURE OF THE (17S)-DIASTEREOMER

Host Biomarkers and Biological Pathways That Are Associated with the Expression of Experimental Cerebral Malaria in Mice

Synthesis of (17R)- and (17S)-17-hydroxy-14, 15-secoandrost-4-en-15-yn-3-one and the X-ray crystal structure of the (17S)-diastereomer

Synthesis of C18–C28 ketone fragment of micromonospolide B possessing 1,3-diene and 1,3-anti-diol functionalities

Synthesis of N-Substituted 3-Oxo-17b- Carboxamide-4-aza-5a-androstanes and the Tautomerism of 3-Oxo-4-aza-5-androstenes

Chemoenzymatic Synthesis of ((4R,6s)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxinan-4-yl)-acetic Acid Tert-Butyl Ester

Synthesis of Cardiotonic Steroids Oleandrigenin and Rhodexin B

Improved Synthetic Route to Dexamethasone Acetate from Tigogenin

Synthesis Of(2e, 6E )-Octadiene-3, 7- Dimethyl-1,8- Diol-1- Acetate